Ni Rui, Ji Xiao-Yun, Cao Ting, Liu Xiu-Wen, Wang Chao, Lu Chao, Peng Angel, Zhang Zhu-Xu, Fan Guo-Chang, Zhang Jin, Su Zhao-Liang, Peng Tian-Qing
International Genome Center, Jiangsu University, Zhenjiang, 212013, China.
Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.
Acta Pharmacol Sin. 2025 Apr;46(4):976-988. doi: 10.1038/s41401-024-01424-3. Epub 2024 Dec 2.
Myocardial dysfunction is a decisive factor of death in septic patients. Cyclophilin F (PPIF) is a major component of the mitochondrial permeability transition pore (mPTP) and acts as a critical mPTP sensitizer triggering mPTP opening. In sepsis, decreased NAD impairs Sirtuin 3 function, which may prevent PPIF de-acetylation. Repletion of NAD with nicotinamide mononucleotide (NMN) reduces myocardial dysfunction in septic mice. In addition, administration of the mPTP inhibitor cyclosporine-A attenuated sepsis-induced myocardial dysfunction, and deletion of PPIF reduced lung and liver injuries in sepsis, leading to increased survival. It is plausible that NAD repletion with NMN may prevent mPTP opening in protecting septic hearts through PPIF de-acetylation and/or inhibition of mitochondrial ROS-mediated PPIF oxidation. In this study we investigated how NMN alleviated myocardial dysfunction in septic mice. Sepsis was induced in mice by injection of LPS (4 mg/kg, i.p.). Then mice received NMN (500 mg/kg, i.p.) or mito-TEMPO (0.7 mg/kg, i.p.) right after LPS injection, and subjected to echocardiography for assessing myocardial function. At the end of experiment, the heart tissues and sera were collected for analyses. In vitro experiments were conducted in neonatal mouse cardiomyocytes treated with LPS (1 µg/mL) in the presence of NMN (500 µmol/L) or mito-TEMPO (25 nmol/L). We showed that LPS treatment markedly increased mitochondrial ROS production and induced lysosomal dysfunction and aberrant autophagy in cardiomyocytes and mouse hearts, leading to inflammatory responses and myocardial injury and dysfunction in septic mice. NMN administration attenuated LPS-induced deteriorative effects. Selective inhibition of mitochondrial superoxide production with mito-TEMPO attenuated lysosomal dysfunction and aberrant autophagy in septic mouse hearts. Notably, LPS treatment significantly increased acetylation and oxidation of PPIF, which was prevented by NMN in mouse hearts. Knockdown of PPIF replicated the beneficial effects of NMN or mito-TEMPO on ROS production, lysosomal dysfunction, aberrant autophagy, and myocardial injury/dysfunction in sepsis. In addition, administration of NMN abrogated LPS-induced ATP5A1 acetylation and increased ATP5A1 protein levels and ATP production in septic mouse hearts. This study demonstrates that NMN modulates the interplay of mitochondrial ROS and PPIF in maintaining normal lysosomal function and autophagy and protecting ATP5A1 and ATP production during sepsis.
心肌功能障碍是脓毒症患者死亡的决定性因素。亲环蛋白F(PPIF)是线粒体通透性转换孔(mPTP)的主要成分,是触发mPTP开放的关键mPTP敏化剂。在脓毒症中,NAD减少会损害沉默调节蛋白3的功能,这可能会阻止PPIF的去乙酰化。用烟酰胺单核苷酸(NMN)补充NAD可减轻脓毒症小鼠的心肌功能障碍。此外,给予mPTP抑制剂环孢素A可减轻脓毒症诱导的心肌功能障碍,而敲除PPIF可减轻脓毒症时的肺和肝损伤,从而提高生存率。用NMN补充NAD可能通过PPIF的去乙酰化和/或抑制线粒体ROS介导的PPIF氧化来防止mPTP开放,从而保护脓毒症心脏。在本研究中,我们研究了NMN如何减轻脓毒症小鼠的心肌功能障碍。通过腹腔注射脂多糖(LPS,4mg/kg)诱导小鼠发生脓毒症。然后在注射LPS后立即给小鼠腹腔注射NMN(500mg/kg)或线粒体靶向抗氧化剂mito-TEMPO(0.7mg/kg),并进行超声心动图检查以评估心肌功能。在实验结束时,收集心脏组织和血清进行分析。在体外实验中,用LPS(1μg/mL)处理新生小鼠心肌细胞,并加入NMN(500μmol/L)或mito-TEMPO(25nmol/L)。我们发现,LPS处理显著增加了心肌细胞和小鼠心脏中线粒体ROS的产生,诱导了溶酶体功能障碍和异常自噬,导致脓毒症小鼠出现炎症反应、心肌损伤和功能障碍。给予NMN可减轻LPS诱导的恶化效应。用mito-TEMPO选择性抑制线粒体超氧化物的产生可减轻脓毒症小鼠心脏中的溶酶体功能障碍和异常自噬。值得注意的是,LPS处理显著增加了PPIF的乙酰化和氧化,而NMN可在小鼠心脏中阻止这种情况发生。敲低PPIF可重现NMN或mito-TEMPO对脓毒症中ROS产生、溶酶体功能障碍、异常自噬以及心肌损伤/功能障碍的有益作用。此外,给予NMN可消除LPS诱导的ATP5A1乙酰化,并增加脓毒症小鼠心脏中ATP5A1蛋白水平和ATP产生。本研究表明,NMN在脓毒症期间调节线粒体ROS和PPIF之间的相互作用,以维持正常的溶酶体功能和自噬,并保护ATP5A1和ATP产生。